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Abstract
Human apurinic/apyrimidinic endonuclease (hApe1) encodes two important functional activities: an
essential base excision repair (BER) activity and a redox activity that regulates expression of a
number of genes through reduction of their transcription factors, AP-1, NFκB, HIF-1α, CREB, p53
and others. The BER function is highly conserved from prokaryotes (E. coli exonuclease III) to
humans (hApe1). Here, we provide evidence supporting a redox function unique to mammalian Apes.
An evolutionary analysis of Ape sequences reveals that, of the 7 Cys residues, Cys 93, 99, 208, 296,
and 310 are conserved in both mammalian and non-mammalian vertebrate Apes, while Cys 65 is
unique to mammalian Apes. In the zebrafish Ape (zApe), selected as the vertebrate sequence most
distant from human, the residue equivalent to Cys 65 is Thr 58. The wild-type zApe enzyme was
tested for redox activity in both in vitro EMSA and transactivation assays and found to be inactive,
similar to C65A hApe1. Substitution of Thr 58 with Cys in zApe, however, resulted in a redox active
enzyme, suggesting that a Cys residue in this position is indeed critical for redox function. In order
to further probe differences between redox active and inactive enzymes, we have determined the
crystal structures of vertebrate redox inactive enzymes, the C65A human Ape1 enzyme and the zApe
enzyme at 1.9 Å and 2.3 Å, respectively. Our results provide new insights on the redox function and
highlight a dramatic gain-of-function activity for Ape1 in mammals not found in non-mammalian
vertebrates or lower organisms.
1.0 Introduction
Redox regulation has been shown to play an important role in modulating the DNA binding
activity of a number of transcription factors including AP-1, NFκB, HIF-1α, HLF, CREB,
PAX, p53 and others [1–11] (reviewed in [12]). As described for AP-1 (Fos/Jun), this regulation
involves the reduction of a critical Cys residue(s) within c-Jun that allows it to bind DNA with
much higher affinity than the oxidized c-Jun [13,14]. The factor responsible for reducing AP-1
was found to be a nuclear factor, termed redox effector factor 1 (Ref1) [15], and later identified
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as apurinic/apyrimidinic endonuclease (Ape1, also referred to as HAP1 or APEX1) [2]. Ape1
is an essential enzyme in the base excision repair pathway catalyzing the second step in the
pathway, cleavage of the phosphodiester backbone 5’ of the abasic site leaving a 3’ hydroxyl
and 5’-deoxyribose phosphate. Deletion of the APE1 gene results in very early embryonic
lethality in mice [16], and knock-down of Ape through the use of a morpholino oligonucleotide
injected in zebrafish embryos results in death at the midblastula transition [17]. In addition,
Ape has been shown to be involved in heart and blood development in zebrafish [17].
The redox activity has been shown to require the N-terminal region of the protein (reviewed
in [12]). The human Ape1 includes 61 residues not present in exonuclease III from E. coli, and
while truncations of up to 40 residues do not affect the redox activity, removal of the 62 N-
terminal residues from the human Ape1 renders this enzyme redox inactive [14,18]. It was
hypothesized that Ape1’s redox activity might involve a Cys residue [14]. Accordingly, each
of the seven Cys residues in Ape1 was substituted individually with Ala, and the resulting
enzymes were tested for their ability to reduce AP-1 thereby allowing it to bind target DNA
specifically in an electrophoretic mobility shift assay (EMSA) [18]. Of these single Cys
mutants, all when reduced retained wild-type redox activity except C65A hApe1, which was
redox inactive. When oxidized, C93A hApe1 was found to be redox active, while all of the
other mutants were inactive. Thus, a redox mechanism involving a disulfide bond between Cys
65 and Cys 93 was proposed [18].
Subsequently, however, several crystal structures of Ape1 have been reported [19–21]
providing three important observations with regard to the redox activity of Ape1. First, no
disulfide bonds are present in any of the structures. Second, Cys 65 is a buried residue in the
conformation of hApe1 observed in the crystal structures and therefore not accessible to the
transcription factors that Ape1 reduces. Third, the structures of hApe1 that have been reported
to date in different crystallographic lattices are remarkably similar. Even in the hApe1-DNA
complex, there are no significant conformational changes in the enzyme [20]. Thus, the
mechanism by which Cys 65 would participate in a potential redox reaction between Ape1 and
a transcription factor requires further investigation. One possible explanation offered by
Gorman et al. [19] was that substitution of Cys 65 with Ala may affect the stability and/or
folding of Ape1 and result in subsequent loss of the redox activity. More recently, the role of
Cys 65 in Ape1’s redox activity has been challenged through the creation of a
Ref1C64A/C64A mouse (C64 is equivalent to the human C65 residue) that was shown to develop
normally [22]; in this study the authors concluded that Cys 65 is not required for redox activity.
Ape vertebrate sequences are highly conserved with the most distantly related sequence, that
of zebrafish Ape (zApe) being 66% identical to the human Ape1. We had initially selected
zebrafish as a potential model system to study the role of Ape in development as mice knockouts
were lethal. However, as reported here, the wild-type zApe lacks redox activity. Thus, we have
not pursued the zebrafish development experiments. We report the results of biochemical
studies including hApe1, zApe, and a zApe mutant engineered to acquire redox function, the
first crystal structures of redox inactive enzymes from vertebrates, and a discussion of the
mechanistic implications for the redox activity of Ape.
2.0 Materials and Methods
2.1 Evolutionary analysis of Ape sequences
Orthologous sequences for APE1 in human and other species except zebrafish were obtained
from the 28 species alignment at the UCSC genome browser [23]. To obtain the zebrafish
APE1 gene sequence, the BLAT web server at UCSC was used to search for matches to the
human APE1 gene within the zebrafish genome. We next identified the 3-nucleotide codons
corresponding to the 7 human Cys residues in the APE1 genes in all species and aligned the
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concatenated Cys codons using CLUSTALW [24]. The branch length for the tree was
determined using PHYLIP [25], and the tree was drawn using MEGAN [26].
2.2 Expression and purification of proteins
GST-hApe1 and mutants—The wild-type and mutant hApe1 proteins were expressed as
GST-fusions. A pGEX-4T hApe1 vector was constructed and confirmed by DNA sequencing.
GST-C65A-hApe1 and GST-C93A-hApe1 mutants were introduced by site-directed
mutagenesis into the pGEX-4T hApe1 vector using the Stratagene Quikchange kit and
confirmed by DNA sequencing. The GST-hApe1 and mutants were transformed into Rosetta
(DE3) E. coli (Novagen), grown in 1 L of LB media with 100 µg/mL ampicillin and 34µg/mL
chloramphenicol until the OD at 600 nm reached 0.5, and then induced overnight with 1 mM
IPTG at 22°C. The cells were harvested by centrifugation, resuspended in PBS buffer, and
purified using the standard glutathione affinity purification protocol (Amersham Biosciences).
Final concentrations of the proteins were calculated from absorbance measurements at 280 nm.
C65A hApe1—Site-directed mutagenesis of a pET28A vector encoding human Ape1 (40–
318) in order to replace Cys 65 with Ala was performed using the Stratagene Quikchange kit
and confirmed by DNA sequencing. Transformation, cell growth, and induction were
performed as described for the GST-Ape1 proteins with the exception that 6 × 1L were grown
and induced at 37°C for 4 hrs. The cultures were harvested by centrifugation at 4000 × g for
30 minutes, and the pellets were stored at −80°C. The cell pellets were each resuspended in 20
mL of 50 mM sodium phosphate buffer pH 7.8, 0.3 M NaCl, 10 mM imidazole, and then lysed
by using a French press (SLM-AMINCO, Spectronic Instruments, Rochester, USA) at 1000
psi. The suspension was centrifuged at 35,000 rpm for 35 min, and the supernatant was then
loaded on a Ni-NTA column at 4°C. The protein was eluted with a linear imidazole gradient
(0.02– 0.5 M), and fractions containing C65A hApe1 were further purified on an S-Sepharose
column using 50 mM MES pH 6.5, 1 mM DTT, and a linear NaCl gradient (0.05–1 M). The
fractions were incubated overnight with 2 units/mg of thrombin to cleave the N-terminal hexa-
His tag and then subjected to a final S-Sepharose chromatographic purification step. The
protein was then concentrated to 54 mg/mL.
Zebrafish Ape—Expression vectors encoding the full-length zApe and zApe (33–310)
proteins in pET15b were constructed using standard subcloning techniques and verified by
DNA sequencing. The zApe vectors were transformed into Rosetta (DE3) E. coli; 6 × 1L
cultures were grown in LB media with 100 µg/ml ampicillin until the OD at 600 nm reached
approximately 0.6 and then induced with 1 mM IPTG at 37°C for 4–5 hrs. Harvesting of cell
pellets, subsequent disruption, and initial Ni-NTA purification were done as described for the
C65A hApe1. The Ni-NTA fractions containing zApe were combined and loaded on a pre-
equilibrated MonoQ (16/10) column after dilution to a final NaCl concentration of 50 mM with
50 mM Tris, pH 8.0. The protein was eluted using a linear NaCl gradient (0.05– 1M), and
fractions containing the zApe were combined, digested with thrombin overnight at 4°C, and
then subjected to a final MonoQ (16/10) column, as described in the previous step. The purified
proteins were concentrated to 50–75 mg/ml in 10 mM Hepes, pH 7.5.
Zebrafish T58C Ape—Site-directed mutagenesis was performed on the full-length zebrafish
Ape pET15b vector using Stratagene’s Quikchange kit and verified by DNA sequencing. The
T58C zApe vector was then transformed into Rosetta (DE3) E. coli. Cell growths and
subsequent purification of the T58C zApe were performed as described for zApe above with
the exception that a Q-sepharose column was used instead of the MonoQ column for the ion
exchange chromatography.
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2.2 Redox assays
Electrophoretic mobility shift assay (EMSA)—EMSAs were performed as described
[27] with the following modifications. 10 µg/µl purified Ape1 protein was reduced with 1.0
mM DTT at 37°C for 10 min and diluted in PBS buffer to yield final concentrations of 2 µg/
µl protein and 0.2 mM DTT. Two µl of reduced Ape1 protein was added to EMSA reaction
buffer, 10 mM Tris pH 7.5, 50 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5% (v/v) glycerol, with
6 µg of nuclear extract (treated with 0.01mM diamide for 10 min) from Hey-C2 cells as the
source of AP-1 protein in a total volume of 18 µl and incubated for 30 min. at room temperature.
Oxidized Ape1 samples were not reduced with DTT prior to addition to the reactions including
Hey-C2 nuclear extracts. One µl poly(dI-dC) · poly(dI-dC) (1µg/ul) (Amersham Biosciences,
Piscataway, NJ) was added for 5 min followed by one µl of the 5’ hexachloro-fluorescein
phosphoramidite (HEX)-labeled double-stranded oligonucleotide DNA (The Midland
Certified Reagent Company, Midland, TX) containing the AP-1 consensus sequence
(5’CGCTTGATGACTCAGCCGGAA-3’) (0.1 pmol), and the mixture was further incubated
for 30 min. at room temperature. The final concentration of DTT in the redox reactions was
0.02 mM. Samples were loaded on a 5% nondenaturing polyacrylamide gel and subjected to
electrophoresis in 0.5X TBE buffer (200 V for 1 h at 4°C) and detected using the Hitachi FMBio
II Fluorescence Imaging System (Hitachi Genetic Systems, South San Francisco, CA). The
HEX fluorophore is excited by a solid-state laser at 532 nm (Perkin-Elmer) and emits a
fluorescent light signal at 560 nm, which is then measured using a 585 nm filter.
Transactivation assay—The stable Skov-3X ovarian cancer cell line with NFkB- Luc gene
(luciferase gene with the NFκB–responsive promoter) was established by transfecting Skov-3X
cells with plasmid pNFκB-Luc (Stratagene, La Jolla, CA) using lipofectamine TM 2000
(Invitrogen Life Technologies, Carlsbad, CA) and screening the luciferase-positive colonies
using a Luciferase Assay Kit ( Promega Corp., Madison, WI). The stable Skov-3X cells with
the NFκB-Luc gene were cotransfected with plasmid pcDNA-wthApe1 or its mutants (pcDNA-
C65A, pcDNA-C93A, pcDNA-C99A, pcDNA-C138A, pcDNA-C208A, pcDNA-C296A,
pcDNA-C310A), or pcDNA- wtzApe or its mutant pcDNA-T58CzApe and a Renilla luciferase
control reporter vector pRL-CMV (Promega Corp., Madison, WI) in a 1:10 ratio using
lipofectamine TM 2000. After 24 h transfection, cells were lysed and the Firefly and Renilla
luciferase activities were assayed using the Dual Luciferase Reporter Assay System ((Promega
Corp., Madison, WI) with Renilla luciferase activity for normalization in a 96-well microtiter
plate luminometer (Thermolabs systems, Franklin, MA). All of the transfection experiments
were performed in triplicate and repeated at least three times in independent experiments.
Student’s t-tests were performed in order to evaluate the statistical significance of the signals
obtained in the assay.
2.3 Crystallographic studies
Crystal structure of C65A hApe1—The concentrated C65A hApe1 protein was diluted
to 10 mg/mL in 10 mM Hepes pH 7.5 and then crystallized by hanging drop vapor diffusion
using 10 mM MES pH 6.0, 7.5 mM Sm(OAc)3, 4% (v/v) Dioxane, 10–20% (w/v) PEG 8000
as the precipitating solution at 20°C. Crystals were soaked in stabilizing solutions including
increasing concentrations of ethylene glycol to a final concentration of 20%, and data were
collected at the Advanced Photon Source, Argonne, IL, beamline 19-ID (Table 1) at 100K and
processed using HKL2000 [28] (see Table 1). The crystal structure was determined by
molecular replacement with AMoRe [29] using 1E9N (PDB accession id) as the search model.
The substitution of Cys 65 for Ala was verified in initial Fo-Fc maps in which a large negative
peak was observed for the sulfhydryl of Cys 65, which was present in the initial model. Iterative
cycles of manual rebuilding in O [30] and crystallographic refinement in CNS [31] were used
to obtain the final structural model. The structure includes 2 Sm3+ atoms coordinated to E96
and D70 or E216 and E217 with the first site including two partially occupied sites for which
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occupancies were estimated by inspection of resulting Fo-Fc electron density maps. These sites
are similar to two of the four Sm3+ sites found in the original hApe1 structure (PDB accession
id 1BIX). The quality of the final model was assessed using PROCHECK [32].
Crystal structure of zApe—Crystals of zApe (33–310) (74 mg/ml in 10mM Hepes, pH 7.5
buffer) were grown by hanging drop vapor diffusion at 20°C using 200 mM Ammonium
acetate, 100 mM Bis-Tris pH 5.5, 7% (w/v) PEG 3350, 2% (v/v) glycerol and 0.8 mM lead
acetate as the precipitating solution. Microseeding was used to improve the size and quality of
the crystals in the same precipitant with the exception that 4% glycerol was used. The crystals
were cryocooled using saturated disodium malonate as the cryoprotectant. Data were collected
at the Advanced Light Source, Berkeley, CA at beamline 4.2.2 and processed using d*trek
[33] (see Table 1). The 2.3 Å resolution zebrafish Ape structure was solved by molecular
replacement with MOLREP [34] using the human Ape1 (PDB accession id, 1BIX) as a search
model. The asymmetric unit was found to contain 3 molecules. Crystallographic refinement
was done using CNS [31]. Three partially occupied Pb2+ sites were included in the model;
occupancies were estimated by inspection of Fo-Fc electron density maps following
crystallographic refinement. Inclusion of non-crystallographic symmetry restraints for main
chain atoms in residues 36–310 of each chain did not affect the final R-values with R=0.201
and Rfree = 0.237 using CNS [31]. The rms deviation for A vs. B was 0.55 Å and for A vs. C
was 0.38 Å. Each refinement cycle was followed by manual model building in O [30]. The
quality of the model was checked throughout refinement by using PROCHECK [32].
Figure 3, Figure 4, and Figure 5 were generated using MOLSCRIPT[35] and RASTER3D
[36]. Figure 7 was generated using GRASP [37]. Coordinates have been deposited with the
PDB: 203C and 203H, zApe and C65A hApe1 structures, respectively.
3.0 Results
3.1 Cell-based analysis of redox activity for hApe1 Cys mutants
The human Ape1 includes seven Cys residues, 65, 93, 99, 138, 208, 296, and 310. In a previous
study [18], the redox activity of single Cys mutants was assessed using an in vitro EMSA redox
assay in which reduction of AP-1 by hApe1 results in a shifted band, indicating the formation
of an AP-1/DNA complex. Of the single Cys mutants tested, only C65A hApe1 was found to
be redox inactive [18].
In order to assess the redox activity of Ape1 and single Cys mutants within a cell providing
data complementary to the in vitro EMSA data, we used a cell-based transactivation assay in
which reduction of NFκB by hApe1 results in a quantifiable luciferase signal (See Materials
and Methods). Although interpretation of in vitro analysis is more straight-forward, the level
of confidence with regard to the biological significance of the results is increased by the
inclusion of cell-based assays. In the transactivation assay, C65A hApe1 is redox inactive with
a signal 1.2-fold that of the control, and C93A hApe1, shows a decrease in redox activity with
a signal 2.0-fold that of the control as compared to wild-type, which is 2.8-fold that of the
control (Fig. 1A). All other Cys mutants had wild-type redox activity in this assay. Statistical
analysis was performed in order to determine that the signal for C65A hApe1 does not differ
significantly from that of the control sample, while the signal for C93A hApe1 does differ
significantly from wild-type hApe1. Thus, results obtained for the transactivation assays for
reduction of NFκB by hApe1 are consistent with those obtained in previous in vitro EMSA
assays for reduction of AP-1 [18], with the exception of the new finding that C93A hApe1 has
intermediate redox activity. This finding was confirmed using the in vitro redox assay as shown
in Figure 1B. Similar to the results from the transactivation assay, GST-C93A-hApe1 has
intermediate redox activity.
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3.2 Evolutionary analysis of Ape sequences
In order to investigate the evolution of the redox function, we have analyzed the codons
corresponding to the seven Cys residues in human Ape1 from vertebrates for which genome
information is available including human, rhesus macaque, mouse, dog, horse, opossum,
platypus, lizard (Anolis Carolinensis), frog (Xenopus tropicalis), and two fish, stickleback and
zebrafish (See Material and Methods). We sought to identify divergence of Cys residues within
vertebrates in order to correlate this with redox activity. An evolutionary tree depicting the
relationship between the vertebrate sequences is shown in Fig. 2A. The reptilian and amphibian
sequences represent a separate branch on the tree from the mammalian sequences. Excluding
platypus in which the residue equivalent to Cys 138 is Arg, all Cys residues are conserved
within the mammalian sequences as shown in Table 2. Within reptilian and amphibian
sequences, Cys is not conserved in the position equivalent to Cys 65 or Cys 138. The residue
equivalent to Cys 65 is either Ser or Thr and that equivalent to Cys 138 is Lys or Glu in non-
mammalian sequences (Table 2).
Thus, based on this analysis of Cys conservation as well as biochemical characterization of
substituted hApe1 enzymes, we predicted that zebrafish Ape (zApe), representing the non-
mammalian vertebrate most distant from humans on the evolutionary tree shown in Fig. 2A,
would be redox inactive. The zebrafish genome includes two copies of AP endonuclease,
zfAPEX1a and zfAPEX1b, with identical coding sequences [17]. Therefore, at the protein level
the two are indistinguishable from one another. The residue equivalent to the human Cys 65
in the zApe sequence is Thr 58 (Table 2, Fig. 2B). In order to test our hypothesis, we analyzed
redox activity for the wild-type zApe in both in vitro and cell-based transactivation assays (Fig.
1). zApe was cloned, expressed, and purified as described in the Materials and Methods for
use in the in vitro redox assays. As predicted, the zApe enzyme is redox inactive.
3.3 Crystal structures of redox inactive Ape enzymes
In order to determine structural differences that may exist between vertebrate redox inactive
and redox active Ape1 enzymes, we have determined the crystal structures of two vertebrate
redox inactive enzymes, C65A hApe1 enzyme and zApe. N-terminally truncated C65A (40–
318) hApe1 and zApe (33–310) enzymes were expressed and purified from E. coli (See
Materials and Methods). The truncations were based on previously reported crystal structures
of the wild-type hApe1 enzyme in which residues 1–42 are disordered [19–21]. The equivalent
truncation in zApe begins with residue 33 as it lacks 7 residues found in the N-terminal region
of the human enzyme as discussed below (Fig. 2B). C65A hApe1 and zApe samples used for
structural studies were found to be redox inactive in redox EMSA assays (data not shown).
Each of the redox inactive enzymes crystallized in a lattice distinct from those previously
reported for wild-type hApe1 (See Table 1 for cell parameters) despite the use of similar
crystallization condition containing Sm(OAc)3 for C65A hApe1 to that of Gorman et al.[19].
The crystal structures were determined by molecular replacement (See Materials and Methods
for details).
Both zApe and C65A hApe1 are monomeric in solution as characterized by size exclusion
chromatography (data not shown). The C65A hApe1 structure (PDB identifier 203H) includes
one molecule in the asymmetric unit, 2 Sm3+ atoms, and 4 acetate molecules as shown in Fig.
3A. Within the repair active site, the Sm3+ atom occupies two sites each of partial occupancy,
with one site coordinated by both Asp 70 and Glu 96 and the second coordinated only to Glu
96. The second Sm3+ atom is coordinated by Glu 216 and Glu 217 on the surface of the
molecule. Two of the acetate molecules form hydrogen-bonding interactions with the backbone
amides of residues Ser 129 and Ser 275; one is hydrogen-bonded to the N-terminus of the
molecule, residue Met 37; and the fourth is hydrogen-bonded to the amine of Lys 78. These
sites potentially represent general anionic binding sites on the surface of hApe1. In the zApe
Georgiadis et al. Page 6
Mutat Res. Author manuscript; available in PMC 2009 August 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
structure (PDB identifier 203C), there are three zApe molecules in the asymmetric unit along
with 3 Pb2+ atoms, one per molecule, which are coordinated in the repair active site by Asp 63
in all sites and by Asp 63 and Glu 89, equivalent to Asp 70 and Glu 96, in two of the three sites
(See Fig. 3B). The three zApe molecules are very similar to one another as shown in Fig. 3C
with pairwise root mean square deviations (rmsds) of 0.48 to 0.86 Å for 276 Cα atoms. Metal
ions bound in the structures of C65A hApe1 and zApe are bound in the “B” site, the putative
post-cleavage metal ion binding site rather than the proposed catalytic “A” site [38].
The crystal structures of both C65A hApe1 and zApe provide new structural information on
the N-terminus of the protein. The C65A hApe1 structure includes 5 additional residues, 37
through 41 (37 – 39 are encoded by the vector), that have not been observed in previously
reported Ape1 structures, even those in which the full-length Ape1 was used [21] (See Fig.
4C). The conformation of these N-terminal residues is partially stabilized by a hydrogen
bonding interaction between the guanidium NH2 of Arg 221 and the carbonyl of Gly 41. No
interactions between residues 37–40 and the rest of the molecule were observed. Each of the
three zApe molecules also have an extended N-terminus as in the C65A hApe1 with one
molecule (designated the B molecule) including a fully ordered N-terminus including residues
33–310 as well as 2 additional N-terminal residues encoded by the vector. The conformation
of the N-terminal residues of zApe (B) differs from that seen in the C65A hApe1 structure and
lacks the hydrogen-bonding interaction observed between Arg 221 and Gly 41; the equivalent
residues in zApe are Lys 214 and Ala 34 as shown in Fig. 4A.
The structure of C65A hApe1 is similar to the wild-type hApe1 structures with rmsds of 0.24–
0.58 Å for superimpositioning of Cα coordinates. The zApe enzyme is also structurally similar
to the human enzymes with rmsds of 0.71–0.76 Å for pairwise comparisons of Cα coordinates
in the three zApe molecules as compared to the C65A or wild-type hApe1 structures. In
particular, for the region of the structure in the vicinity of residue 65, not only the Cα atoms
but all the atoms in the amino acids superimpose well including the Cβ atoms in Ala 65 and
Cys 65 in the C65A and wild-type hApe1 structures, respectively, as shown in Fig. 4B. The
chemical environment immediately surrounding Thr 58, the residue equivalent to Cys 65 in
hApe1, is conserved in both zApe and wild-type hApe1 structures with identical amino acids
in very similar conformations (Fig. 4C). Further away from Thr 58, the residues in zApe and
hApe1 differ as shown in Fig. 4C. Other structural differences between the zApe and hApe1
enzymes include the loop regions, residues 114–122 and 121–129 in zApe and C65A hApe1,
respectively, and residues 238–241 in zApe corresponding to a loop that is one residue longer
in hApe1, residues 245–249. We also note that of the 7 Cys residues present in the wild-type
hApe1, 5 are structurally conserved in the zApe enzyme, namely, 93, 99, 208, 296, and 310 as
shown in Fig. 5.
3.4 The T58C zApe enzyme is redox active
Based on our structural and evolutionary analysis, we predicted that substitution of Thr 58 with
Cys would confer redox activity to zApe. The amino acid sequence of zebrafish Ape1 is 66%
identical to that of the human Ape1 retaining all catalytic residues required for the endonuclease
activity but lacking Cys residues equivalent to Cys 65 and Cys 138 in the hApe1. Other
differences in sequence include a deletion of 7 residues in the N-terminus corresponding to
residues 15–21 in the human enzyme and deletion of the residue corresponding to 248 (Fig.
2B). The T58C zApe was expressed and purified from E. coli (see Methods) and found to be
redox active with near wild-type human Ape1 (hApe1) activity in the EMSA as shown in Fig.
6A. Similarly, T58C zApe has near wild-type human Ape1 redox activity in the transactivation
assay (Fig. 6). Transactivation assays in which AP-1 is reduced resulting in an increased
luciferase signal were also performed for hApe1, C65A hApe1, zApe, and T58C zApe, and
results obtained were very similar to those obtained for the reduction of NFκB (data not shown).
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Of particular interest is the fact that T58C zApe effectively reduces human transcription factors
including AP-1 and NFκB in these experiments. The calculated pI of zApe is 5.8 while that of
hApe1 is 8.3, and examination of the electrostatic potential surfaces mapped to the molecular
surface of the two enzymes reveals that in the vicinity of the redox active residue, the
electrostatic potential surface is substantially different in the two enzymes. Notably, zApe is
more negatively charged as represented by red regions in Fig. 7; blue regions indicate positively
charged areas. Cys 65 is located just behind Glu 87; similarly, Thr 58 is just behind Glu 80
(see Fig. 7). Comparison of the molecular surfaces calculated for wild-type zApe and hApe1
(1BIX) further highlight that although residues surrounding the redox active Cys (or Thr in
zApe) are conserved, residues on the surface of the molecules in this same region of the
structure are not conserved, and thus the properties of the molecular surfaces are not conserved.
In contrast, the electrostatic potential surfaces of C65A hApe1 and hApe1 are very similar, and
with the exception of the N-terminal residues 37–42 found only in the C65A hApe1 structure,
the molecular surfaces are also quite similar. Thus, the surface properties of the redox active
T58C zApe would be expected to be similar to those of the wild-type zApe. We further note
that this “redox” surface of the molecule is relatively flat with no obvious binding pockets deep
enough to accommodate a small aromatic molecule.
4.0 Discussion
The results presented here impact our current understanding of the mechanism of Ape1’s redox
activity. First, our evolutionary sequence analysis suggests that the redox function is found
only in mammals and results from the acquisition of Cys 65. As shown in Table 2, the equivalent
residue is either Ser or Thr in non-mammalian vertebrate Ape sequences. While Cys 138 is
also conserved in most mammals and not in non-mammalian vertebrates, the platypus has a
Ser residue in the equivalent position, and substitution of Cys 138 has no effect on redox activity
in in vitro EMSA[18] or transactivation assays. The functional importance of Cys 65 has been
demonstrated by loss of redox function resulting from substitution of this residue with Ala in
transactivation assays, consistent with a previous report for EMSA redox analysis of Ala
mutants [18]. A potential redox role for Cys 93 is suggested by transactivation assays and
EMSA redox analysis in which C93A hApe1 has less redox activity than the wild-type enzyme
albeit significantly more activity than the C65A hApe1. However, we note that Cys 93 is
conserved in non-mammalian vertebrate sequences including zApe and that this enzyme is not
redox active.
In assessing the results of the transactivation assays, it is important to consider the role of the
base excision repair activity of hApe1 as well as its redox activity. As previously reported and
in data not shown here, we have assayed all of the single Cys mutants and found that they retain
wild-type repair activity [39]. Thus, it is unlikely that the reduction in redox activity observed
for C65A and C93A hApe1 results from a reduction in repair activity. In addition, the results
obtained for the in vitro and cell-based transactivation assays are entirely consistent suggesting
that each is in fact monitoring the same activity of hApe1, namely the redox activity.
The gain of redox function observed for the T58C zApe provides compelling evidence for the
role of Cys 65 in the redox activity of Ape1. Further, our results directly contradict the
conclusion that Cys 65 is not critical for the redox activity of Ape1 as has recently been
suggested in the C64A Ape1 mouse knock-in experiments [22]. Of particular relevance is the
fact that the T58C zApe enzyme reduces human AP-1 and NFκB in our assays. Through
comparative structural analysis, the crystal structures of the redox inactive C65A hApe1 and
wild-type zApe were shown overall to be quite similar to the redox active wild-type hApe1
structure. Thus, it is unlikely that substitution of Ala for Cys 65 in the hApe1 results in a
conformational change accounting for its loss of redox activity. One possible conclusion from
our structural analysis is that the previously reported structures of the wild-type hApe1 enzyme
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do not represent this molecule in a redox active state. This would account for the overall
structural similarity between the redox inactive and redox active enzymes, which extends to
the repair active sites in which metal ions are bound in all of the structures. The analysis of the
N-terminal regions of the zApe and C65A hApe1 supports previous results on deletion analysis
of hApe1 in which the enzyme lacking 36 amino acid residues from the N-terminus retained
redox activity. Our present analysis further suggests that while there is a requirement for N-
terminal residues, sequence conservation of the N-terminal residues is not required for the
redox function. This is supported by the fact that the N-terminal residues are poorly conserved
between zApe and hApe1 (Fig. 2B).
We propose that the hApe1 enzyme undergoes a conformational change in order to reduce
transcription factors. Although we cannot at this time detail that conformational change, we
propose that it ultimately involves exposure of Cys 65. This putative mechanism is consistent
with the fact that Ape1 reduces a large number of structurally unrelated transcription factors
including bZip family members AP-1 and HLF, immunoglobulin-like factors NFkB and p53,
the homeodomain-like factor PAX, and the bHLH-PAS domain factor HIF-1α and presumes
a thiol exchange type of mechanism, which is consistent with the requirement for Cys 65. As
revealed in a comparison of the molecular surfaces of zApe and hApe1, there is little
conservation both in the detailed surface features as well as the electrostatic potential surface
that would be encountered by a transcription factor. Clearly the surfaces of the molecules prior
to a conformational change are not conserved and therefore do not provide a conserved “binding
site”. Therefore, we propose that in order to reduce the many structurally unrelated transcription
factors, Ape changes conformation resulting in a binding site that will accommodate these
different transcription factors and in which Cys 65 is now accessible. As noted above, within
the immediate vicinity of Cys 65 or its equivalent, the chemical environment is highly
conserved. While it is possible that DNA plays a role in the interactions of hApe1 and the
transcription factors that it reduces, hApe1 was previously reported to cross-link to the DNA-
binding domain of c-Jun in the absence of DNA[14]. In conclusion, our results provide new
insights regarding the evolution of the redox function and a structural basis for beginning to
elucidate the mechanism by which Ape1 reduces transcription factors.
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Figure 1.
(A) Effect of human Ape1 and cysteine mutants on NFκB transactivation in a cell-based
reporter assay system. SKOV-3X cells were transfected with a NFκB –Luc construct
containing an NFκB –response promoter and driving the expression of a luciferase gene. The
cells were cotransfected with plasmid pcDNA-wild-type zApe1, pcDNA-wild-type hApe1 or
its mutants (pcDNA-C65A, pcDNA-C93A, pcDNA-C99A, pcDNA-C138A, pcDNA-C208A
pcDNA-C296A, pcDNA-C310A) and a Renilla luciferase control reporter vector pRL-CMV.
After a 24 h transfection period, cells were lysed and Firefly and Renilla luciferase activities
were assayed using Renilla luciferase activity for normalization. All of the transfection
experiments were performed in triplicates and repeated at least three times in independent
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experiments. Error bars denote standard deviation. Data are means± standard error from a
representative experiment and the Student’s t-tests were performed. *Significant difference at
the p< 0.01 level comparing the cysteine mutants and wt-hApe1. ‡ indicates a significant
difference at the p< 0.01 level comparing the mutant with C65A hApe1, while ‡‡ indicates no
significant difference (p> 0.05) compared with C65A. (B) Effect of wild-type zApe1, wild-
type hApe1 and hApe1 C65A and C93A mutants on AP-1-DNA binding in a redox EMSA
assay. The Ape proteins were reduced using 1mM DTT and then diluted to a final concentraton
of 0.02mM DTT, which is used in the negative control lane 5. Reduced proteins with 0.02 mM
DTT or oxidized (unreduced) proteins were preincubated with Hey-C2 nuclear extract, treated
as described in Materials and Methods, for 30 min. Oxidized proteins (Lane 6–9) did not
stimulate extract AP1-DNA binding. Reduced wild-type hApe1 (Lane 2) enhanced AP-1-DNA
binding, reduced wild-type zApe1 and C65A-hApe1 (Lane 1 and 3) did not, and C93A-hApe1
(Lane 4) demonstrated an intermediate binding pattern. Specificity of AP-1 binding was
determined using antibody to AP-1 (data not shown).
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Figure 2.
(A) An evolutionary tree is shown for vertebrate Ape sequences based on analysis of the codons
in each sequence aligned with the 7 Cys codons in hApe1. Branch length is indicated as a
number on each branch. Mammalian and non-mammalian vertebrate sequences are found in
distinct branches with zebrafish representing the sequence most evolutionarily distant from the
human Ape1. (B) PSI-BLAST sequence alignment of hApe1 and zApe sequences, top and
bottom respectively. Identical residues are shown in the intervening row between the two
sequences and conserved residues are indicated by a (+). The two sequences are 66% identical
overall. Positions of Cys residues are denoted with an (*).
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Figure 3. Crystal structures of redox inactive Ape enzymes
(A) The crystal structure of C65A hApe1 is shown as a ribbon rendering in red. Bound Sm3+
ions are shown as gold spheres and acetate ions in ball-and-stick representations in cyan. The
two Sm3+ ions with overlapping positions occupy slightly different positions within the same
binding site within the repair active site and have each been modeled with partial occupancy.
(B) The crystal structure of wild-type zApe including three molecules in the asymmetric unit
is shown. Each molecule is shown as a ribbon rendering with the A molecule in gold, B in blue,
and C in purple. Pb2+ ions bound within the repair active site are shown as green spheres.
(C) A comparison of the three zApe molecules is shown. The three zApe molecules are shown
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superimposed in the same ribbon rendering and same color scheme as in (B). The molecules
are very similar to one another with differences limited to loop regions.
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Figure 4. Comparison of wild-type hApe1 with redox inactive enzymes
(A) Ribbon renderings of C65A hApe1(red) and zApe (blue) are shown highlighting the
differences in the N-terminal region of the protein with structurally equivalent residues R221
and G41 in hApe1 vs. K214 and A34 in zApe shown in ball-and-stick models. (B) Ball-and-
stick renderings are shown as a stereo pair for the superimposed C65A hApe1 (red) and the
hApe1 (green) structures in the region of residue 65 highlighting the similarities in the two
structures. Ala 65 is shown in yellow superimposed on the wild-type Cys 65, shown in navy.
(C) A similar comparison of structural conservation in the vicinity of Cys 65 is shown as a
stereo pair for wild-type zApe crystal structure (B-molecule in blue) with Thr 58 in red
superimposed on the wild-type hApe1 structure (green) with Cys 65 in navy. Labeled residues
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farther from Thr 58 differ in the two enzymes; those preceded by a “z” indicate the zApe
residue, otherwise from human Ape1.
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Figure 5. Comparison of Cys residues in zApe and hApe1
hApe1 is shown in a green ribbon rendering, zApe in blue. Cys residues are shown in a ball-
and-stick model with conserved Cys residues shown in magenta, and those associated only
with hApe1 in green and zApe in blue. Five of the Cys residues found in hApe1 are also found
in zApe. Residue numbers with a “z” prefix indicate the zApe sequence.
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Figure 6.
(A) Effect of wild-type hApe1, wild-type zApe1, and its mutant protein on AP-1-DNA binding
in a redox EMSA assay. The Ape1 proteins; wild-type hApe1, wild-type zApe1 and zebrafish
Ape1 mutated at position 58 from a Thr to a Cys (T58C) were reduced by 1 mM DTT and then
diluted as described in Materials and Methods and in Figure 1. Reduced proteins with 0.02mM
DTT or oxidized (unreduced) proteins were preincubated with oxidized nuclear extract and
assayed using EMSA as previously described. Oxidized (unreduced) proteins did not stimulate
AP-1-DNA binding (Lane 6–8). Reduced wild-type hApe1, zApe1 mutant (T58C) zApe (Lane
3, and 5) enhanced AP-1-DNA binding and wild-type zApe1 (Lane 4) did not. (B) Effect of
zApe1 mutant (T58C zApe1), human wild-type Ape1 and its mutant C65A (redox deficient/
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repair active Ape1) on NFκB transactivation. The stable Skov-3X cells with NFκB – Luc were
cotransfected with plasmid pcDANA-T58C zApe1, pcDNA-wtApe1 or pcDNA-C65A-Ape1
and a Renilla luciferase control reporter vector pRL-CMV. After 24 h transfection, cells were
lysed and Firefly and Renilla luciferase activities were assayed with Renilla luciferase activity
for normalization. All of the transfection experiments were performed in triplicates and
repeated at least three times in independent experiments. Error bars denote standard deviation.
Data are means± standard error from a representative experiment and Student’s t-tests were
performed. * indicates a significant difference, with p< 0.01 for C65A hApe1 compared with
wthApe1 and for T58C zApe vs. C65A hApe1. There is no statistically significant difference
between wthApe1 and T58C zApe.
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Figure 7. Comparison of electrostatic potential surfaces
(A) The electrostatic potential surface of wild-type hApe1 is shown for the face of the molecule
expected to be involved in its redox activity. Red regions are negatively charged, blue,
positively charged. As a point of reference in each panel, either Glu 87 or Glu 80 is labeled
along with R301 or R293. Cys 65, Ala 65, or Thr 58 in panels A, B, and C, respectively, is a
buried residue located behind Glu 87 or Glu 80. Although it is not solvent accessible, a
conformational change in the structure would likely expose Cys 65 on this face of the molecule.
(B) The electrostatic potential surface of the C65A hApe1 is shown for the same face as that
shown in (A). C65A hApe1 and hApe1 have similar patterns of charged regions and surface
features. The C65A hApe1 differs from that of the wild-type structure in the vicinity of the N-
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terminus, denoted as N in all images, as there are more ordered residues present in this structure.
(C) The electrostatic potential surface of zApe is shown for the same face of the molecule as
in (A) and (B) and is distinctly different from that of the hApe1 enzymes. Most notably, this
surface in zApe is more negatively charged, consistent with its calculated acidic pI. The
molecular surface is also distinct in part due to the structure of the N-terminal portion of the
protein.
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Table 1
Crystal structures of C65A hApe1 and zApe
Crystallographic Data C65A hApe1 zApe
Cell dimensions (Å) a=46.69 a=54.74
b=143.60 b=117.89
c=45.39 c=86.01
β=98.41 °
Space group P21212 P21
Resolution range (Å) 33.0-1.90 49.15-2.30
Total number of reflections 118818 141633
Number of unique reflections 22948 46075
Completeness (%) 93.4 (92.1) 96.5 (85.5)
aRmerge 0.07 (0.16) 0.059 (0.26)
I/σ 33.1 (13.2) 14.3 (3.4)
Refinement statistics
bRvalue 0.177 0.199
bRfree 0.226 0.236
Rmsd bonds Å 0.0045 0.0058
Rmsd angles ° 1.37 1.38
Average B-factor 17.6 28.3
No. of ions 2 / 4 (Sm/OAc) 3 (Pb)
No. of waters 326 362
Ramachandran plot statistics
Most favored 87.3 86.9
Addn. favored 12.7 12.0
Generously allowed 1.1
Highest resolution shells are (1.97-1.90) and (2.4- 2.30) for C65A hApe1 and zApe, respectively.
a
Rmerge= ΣΣi|Ii-<I>|/ Σ<I> where I is the integrated intensity of a reflection.
b
Rvalue=Σhkl∥Fobs − kFcalc|/Σhkl|Fobs|. 5% of all reflections were omitted from refinement, and Rfree is the same statistic calculated for these
reflections.
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ho
ds
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ls
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ig
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en
ts
 o
f s
eq
ue
nc
es
 a
nd
 sp
ec
ie
s. 
Th
e 
lin
e 
se
pa
ra
tin
g 
Pl
at
yp
us
 fr
om
 L
iz
ar
d 
w
ith
in
 th
e 
ta
bl
e 
m
ar
ks
 th
e 
di
vi
si
on
 b
et
w
ee
n 
m
am
m
al
ia
n 
sp
ec
ie
s a
bo
ve
 th
e 
lin
e
an
d 
no
n-
m
am
m
al
ia
n 
ve
rte
br
at
es
 b
el
ow
 th
e 
lin
e.
 T
he
 c
on
se
ns
us
 se
qu
en
ce
 is
 in
di
ca
te
d 
fo
r e
ac
h 
po
si
tio
n 
on
 th
e 
bo
tto
m
 li
ne
.
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